Plant Bioscience Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Plant Bioscience Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014093
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:15
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Plant Bioscience Ltd (PBL) is a technology management company that specializes in plant, food and microbial science. The company provides intellectual property management, patent advisory and technology transfer services to life science companies and investors. Its patent consultation and management services include IP identification and assessment, IP strategy definition and implementation, initial patent application drafting, IP portfolio management, and IP portfolio assessment and due diligence. The company provides technologies for licensing in-plant science, general biotechnology, health and medicine, microbiology, nutritional and food technology industries. PBL works in partnership with research institutes and universities. It is headquartered in Norwich, the UK.

Plant Bioscience Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Plant Bioscience Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Plant Bioscience Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Plant Bioscience Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Plant Bioscience Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Plant Bioscience Ltd, Pharmaceuticals & Healthcare, Deal Details 9
Licensing Agreements 9
Dicerna Pharma Enters Into Licensing Agreement With Plant Bioscience For Baulcombe & Hamilton RNAi Patents 9
Thermo Fisher Scientific Enters into Licensing Agreement with Plant Bioscience 10
Alnylam Pharma Enters Into Licensing Agreement With Plant Bioscience For Baulcombe Patent 11
Plant Bioscience Ltd – Key Competitors 12
Plant Bioscience Ltd – Key Employees 13
Plant Bioscience Ltd – Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Joint Venture 14
Appendix 15
Methodology 15
About GlobalData 15
Contact Us 15
Disclaimer 15

List of Tables
Plant Bioscience Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Plant Bioscience Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Plant Bioscience Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Plant Bioscience Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Plant Bioscience Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Plant Bioscience Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Dicerna Pharma Enters Into Licensing Agreement With Plant Bioscience For Baulcombe & Hamilton RNAi Patents 9
Thermo Fisher Scientific Enters into Licensing Agreement with Plant Bioscience 10
Alnylam Pharma Enters Into Licensing Agreement With Plant Bioscience For Baulcombe Patent 11
Plant Bioscience Ltd, Key Competitors 12
Plant Bioscience Ltd, Key Employees 13
Plant Bioscience Ltd, Joint Venture 14

★海外企業調査レポート[Plant Bioscience Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ERBA Molecular Ltd:企業の製品パイプライン分析2018
    Summary ERBA Molecular Ltd (ERBA Molecular), formerly Lumora Ltd, a subsidiary of Erba Diagnostics Mannheim GmbH, is a medical equipment company that offers innovative molecular diagnostics. The company provides technology that is used in medical diagnostics, agricultural, livestock and crops, food …
  • Driver and Vehicle Standards Agency:企業の戦略的SWOT分析
    Driver and Vehicle Standards Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • International Flavors & Fragrances Inc.:企業の戦略・SWOT・財務情報
    International Flavors & Fragrances Inc. - Strategy, SWOT and Corporate Finance Report Summary International Flavors & Fragrances Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Kohl’s Corp (KSS):企業の財務・戦略的SWOT分析
    Kohl's Corp (KSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Nuance Communications Inc (NUAN):企業の財務・戦略的SWOT分析
    Nuance Communications Inc (NUAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Abano Healthcare Group Ltd (ABA):企業の財務・戦略的SWOT分析
    Summary Abano Healthcare Group Ltd (Abano Healthcare), formerly ElderCare New Zealand Ltd, is a healthcare service provider that offers dental, audiology, radiology and medical services. The company also operates business in community pathology and radiology sector; and healthcare markets such as ab …
  • Agile Therapeutics Inc (AGRX):医療機器:M&Aディール及び事業提携情報
    Summary Agile Therapeutics Inc (Agile) is a healthcare company that develops and commercializes prescription contraceptive products for women. The company provides contraceptive patch containing the active ingredients levonorgestrel and ethinyl estradiol and progestin-only birth control patch. Its p …
  • Gold Fields Limited:企業の戦略・SWOT・財務情報
    Gold Fields Limited - Strategy, SWOT and Corporate Finance Report Summary Gold Fields Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Ansaldo Energia SpA:電力:M&Aディール及び事業提携情報
    Summary Ansaldo Energia SpA (Ansaldo Energia), a subsidiary of CDP Equity SpA, is a power generation company and a supplier of power plant equipment and related services. It provides power plant equipment such as gas turbines, steam turbines, turbo generators, and hydro-generators used in fossil fue …
  • Arch Therapeutics Inc (ARTH):医療機器:M&Aディール及び事業提携情報
    Summary Arch Therapeutics Inc (Arch Therapeutics) is a medical device company that develops self-assembling barrier technologies to improve interventional wound care outcomes. The company offers hemostasis and sealant products to seal and protect leaking and bleeding tissue. It provides intervention …
  • BKW AG (BKW)-エネルギー分野:企業M&A・提携分析
    Summary BKW AG (BKW) is a provider of energy services. The company plans, builds and operates infrastructure to produce and supply energy. It generates electricity from varied fuel sources such as hydro, nuclear, fossil, and renewable sources primarily, wind and small hydro, besides solar and biomas …
  • UGI Corp (UGI):企業の財務・戦略的SWOT分析
    UGI Corp (UGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Plenus Company Limited
    Plenus Company Limited - Strategy, SWOT and Corporate Finance Report Summary Plenus Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Saudi Arabian Oil Co:企業の戦略的SWOT分析
    Saudi Arabian Oil Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Dynavax Technologies Corp (DVAX):企業の財務・戦略的SWOT分析
    Dynavax Technologies Corp (DVAX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Twilio Inc (TWLO):企業の財務・戦略的SWOT分析
    Twilio Inc (TWLO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Medidata Solutions Inc (MDSO)-医療機器分野:企業M&A・提携分析
    Summary Medidata Solutions Inc (Medidata) is a provider of cloud based solutions for life sciences sectors. It offers wide range of advanced tools for data & analytics, planning, data capture, study management, monitoring, payments, and platform services. The company offers technology and data analy …
  • Givaudan SA:企業の戦略・SWOT・財務情報
    Givaudan SA - Strategy, SWOT and Corporate Finance Report Summary Givaudan SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Globo Comunicacao e Participacoes S.A.:企業の戦略的SWOT分析
    Globo Comunicacao e Participacoes S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Centinel Spine Inc:医療機器:M&Aディール及び事業提携情報
    Summary Centinel Spine Inc (Centinel Spine) is a medical device company that manufactures and markets spinal devices. The company develops integrated interbody fusion technologies. It offers lumbar and cervical solutions. Centinel Spine’s product includes ALTOS, a posterior cervical thoracic stabili …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆